Luye Pharma Group Ltd.
Luye Pharma Group is a Yantai-based, Hong Kong-listed (HKEX: 2186) drugmaker with a central nervous system focus. Its antidepressant toludesvenlafaxine (Ruoxinlin, LY03005) is approved in China.
| Headquarters | Yantai, China |
|---|---|
| Listing | HKEX:02186 |
| Lead asset / stage | toludesvenlafaxine (Ruoxinlin; LY03005) Approved — China |
| Latest event | Luye Pharma announced its 2026 interim results. |